Insulin-like growthfactor II (human reduced) (9CI) (67512-18-9)
| Identification |
| Properties |
| Safety Data |
| |
 |
Other Product
- Insulin-like growthfactor II (human)
- Insulin-like growthfactor I (human reduced), 59-L-valine- (9CI)
- Insulin-like growthfactor I (human reduced), 59-L-threonine- (9CI)
- 1-13-Somatotropin(swine reduced), 1-L-methionine-12-L-valine-, (13®1')-protein with 3-L-arginine insulin-like growthfactor I (human) (9CI)
- Insulin-like growthfactor I (human), N-L-methionyl-
- Transforming growthfactor b3 (human reduced) (9CI)
- Insulin II (Xenopuslaevis-A reduced) (9CI)
- Fibroblast growthfactor, acidic (human brain protein moiety reduced) (9CI)
- Fibroblast growthfactor, acidic (human brain protein moiety reduced) (9CI)
- Transforming growthfactor b1 (human clone lbC1 reduced) (9CI)
- Insulin II (Xenopuslaevis-B reduced) (9CI)
- Insulin-like growthfactor I (human),28-glycine-29-glycine-31-de-L-tyrosine-33-de-L-serine-34-de-L-serine-35-de-L-serine-36-de-L-arginine-37-de-L-arginine-(9CI)
- Guanylatecyclase-activating peptide II (human reduced) (9CI)
- insulin-like growth factor II, Leu(27)-
- Transforming growthfactor b2 (human) (9CI)
- Relaxin II (human-A reduced)
- 2-155-Fibroblast growthfactor, basic (human clone lKB7/lHFL1 precursor reduced) (9CI)
- Transforming growthfactor a (swine reduced) (9CI)
- Transforming growthfactor a (cattle reduced) (9CI)
- Relaxin II (human-B reduced)
